Loading...
Loading...
John Carter of SimplerTrading.com was guest on Friday's edition of Benzinga's #PreMarket Prep and discussed why he bought shares of
Sucampo Pharmaceuticals, Inc., a biopharmaceutical company with a focus on research and development of drugs to treat gastrointestinal, ophthalmic, and oncology-based inflammatory disorders.
Carter noted that shares of Sucampo hit fresh 52-week highs on Thursday (note: shares hit new 52-week highs again on Friday before trading off). He suggested that the stock "does not care what the market is doing," or – a "
honey badger stock."
Carter continued that he has been following only five stocks the past week, including Amazon.com, Inc. AMZN, Apple Inc. AAPL, Google Inc GOOG GOOGL, Netflix, Inc. NFLX and Tesla Motors Inc TSLA.
The investment expanded on Tesla as the stock performed well during Thursday's trading session, the issue still has a large amount of shares that are short, implying the stock can have an "exaggerated" move.
Finally, Carter advised that in this volatile market, traders should keep their focus on a few key items. He stated he only follows the five stocks mentioned, the overall indices, and any "honey badger" stocks that may appear.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst Ratings#PreMarket PrepBiopharmaceuticalHonedy Badger StockJohn CarterSucampo Pharaceuticals
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in